The role of the Niemann-Pick disease, type C1 protein in adipocyte insulin action

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Fletcher, Rachael ^a   Gribben, Christopher ^a   Ma, Xuiquan ^a   Burchfield, James G ^a   Thomas, Kristen C ^a   Krycer, James R ^a,b   James, David E ^a,c   Fazakerley, Daniel J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; LIVER X RECEPTOR; PROTEIN KINASE B;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; GENE; GENE EXPRESSION; GLUCOSE TRANSPORT; GLUT4 GENE; HORMONE ACTION; LIPID METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NPC1 GENE; OBESITY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84956666210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116042     Document Type: Article

References (54)

1. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981-990.
2. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638-645. (Pubitemid 351601209)
3. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
4. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
5. Shu XO, Long J, Cai Q, Qi L, Xiang YB, et al. (2010) Identification of new genetic risk variants for type 2 diabetes. PLoS Genet 6: e1001127.
6. Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, et al. (2010) A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 42: 864-868.
7. Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5: 16.
8. Infante RE, Radhakrishnan A, Abi-Mosleh L, Kinch LN, Wang ML, et al. (2008) Purified NPC1 protein: II. Localization of sterol binding to a 240-amino acid soluble luminal loop. J Biol Chem 283: 1064-1075.
9. Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, et al. (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137: 1213-1224.
10. Lloyd-Evans E, Platt FM (2010) Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic 11: 419-428.
11. Robiou-du-Pont S, Bonnefond A, Yengo L, Vaillant E, Lobbens S, et al. (2013) Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Int J Obes (Lond) 37: 980-985.
12. Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, et al. (2009) Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 41: 157-159.
13. Al-Daghri NM, Cagliani R, Forni D, Alokail MS, Pozzoli U, et al. (2012) Mammalian NPC1 genes may undergo positive selection and human polymorphisms associate with type 2 diabetes. BMC Med 10: 140.
14. Jelinek D, Millward V, Birdi A, Trouard TP, Heidenreich RA, et al. (2011) Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance. Hum Mol Genet 20: 312-321.
15. Jelinek D, Castillo JJ, Garver WS (2013) The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage has impaired glucose tolerance independent of body weight. Gene 527: 65-70.
16. Ong QR, Lim ML, Chua CC, Cheung NS, Wong BS (2012) Impaired insulin signaling in an animal model of Niemann-Pick Type C disease. Biochem Biophys Res Commun 424: 482-487.
17. Xu J, Dang Y, Ren YR, Liu JO (2010) Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci U S A 107: 4764-4769.
18. Shewan AM, van Dam EM, Martin S, Luen TB, Hong W, et al. (2003) GLUT4 recycles via a trans-Golgi network (TGN) subdomain enriched in Syntaxins 6 and 16 but not TGN38: involvement of an acidic targeting motif. Mol Biol Cell 14: 973-986. (Pubitemid 36337446)
19. Piper RC, Hess LJ, James DE (1991) Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol 260: C570-580.
20. Govers R, Coster AC, James DE (2004) Insulin increases cell surface GLUT4 levels by dose dependently discharging GLUT4 into a cell surface recycling pathway. Mol Cell Biol 24: 6456-6466. (Pubitemid 38891144)
21. Dahl NK, Reed KL, Daunais MA, Faust JR, Liscum L (1992) Isolation and characterization of Chinese hamster ovary cells defective in the intracellular metabolism of low density lipoprotein-derived cholesterol. J Biol Chem 267: 4889-4896.
22. Sugimoto Y, Ninomiya H, Ohsaki Y, Higaki K, Davies JP, et al. (2001) Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells. Proc Natl Acad Sci U S A 98: 12391-12396. (Pubitemid 33019956)
23. Coughlin SR, Escobedo JA, Williams LT (1989) Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science 243: 1191-1194. (Pubitemid 19081146)
24. Bryant NJ, Govers R, James DE (2002) Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3: 267-277. (Pubitemid 34619262)
25. Keller SR (2003) The insulin-regulated aminopeptidase: a companion and regulator of GLUT4. Front Biosci 8: s410-420.
26. Rigamonti E, Helin L, Lestavel S, Mutka AL, Lepore M, et al. (2005) Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circ Res 97: 682-689. (Pubitemid 41416337)
27. Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, et al. (2003) Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A 100: 5419-5424. (Pubitemid 36542720)
28. Cenedella RJ (2009) Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 44: 477-487.
29. Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, et al. (1999) Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13: 1961-1971. (Pubitemid 29517626)
30. Thorn H, Stenkula KG, Karlsson M, Ortegren U, Nystrom FH, et al. (2003) Cell surface orifices of caveolae and localization of caveolin to the necks of caveolae in adipocytes. Mol Biol Cell 14: 3967-3976. (Pubitemid 37186301)
31. Gonzalez-Munoz E, Lopez-Iglesias C, Calvo M, Palacin M, Zorzano A, et al. (2009) Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes. Endocrinology 150: 3493-3502.
32. Chen J, Capozza F, Wu A, Deangelis T, Sun H, et al. (2008) Regulation of insulin receptor substrate-1 expression levels by caveolin-1. J Cell Physiol 217: 281-289.
33. Pederson TM, Kramer DL, Rondinone CM (2001) Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 50: 24-31. (Pubitemid 32047976)
34. Couet J, Sargiacomo M, Lisanti MP (1997) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272: 30429-30438. (Pubitemid 27512253)
35. Pike LJ, Casey L (1996) Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J Biol Chem 271: 26453-26456. (Pubitemid 26359038)
36. Pike LJ, Miller JM (1998) Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J Biol Chem 273: 22298-22304. (Pubitemid 28399788)
37. Laux T, Fukami K, Thelen M, Golub T, Frey D, et al. (2000) GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol 149: 1455-1472.
38. Gao X, Lowry PR, Zhou X, Depry C, Wei Z, et al. (2011) PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc Natl Acad Sci U S A 108: 14509-14514.
39. Partovian C, Ju R, Zhuang ZW, Martin KA, Simons M (2008) Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells. Mol Cell 32: 140-149.
40. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, et al. (2008) IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7: 421-433. (Pubitemid 351598028)
41. Blot V, McGraw TE (2006) GLUT4 is internalized by a cholesterol-dependent nystatin-sensitive mechanism inhibited by insulin. EMBO J 25: 5648-5658. (Pubitemid 44967749)
42. Reverter M, Rentero C, de Muga SV, Alvarez-Guaita A, Mulay V, et al. (2011) Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly, and function. Mol Biol Cell 22: 4108-4123.
43. Nishimura T, Uchida Y, Yachi R, Kudlyk T, Lupashin V, et al. (2013) Oxysterol-binding protein (OSBP) is required for the perinuclear localization of intra-Golgi v-SNAREs. Mol Biol Cell.
44. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, et al. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733. (Pubitemid 32144519)
45. Le Lay S, Krief S, Farnier C, Lefrere I, Le Liepvre X, et al. (2001) Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem 276: 16904-16910.
46. Wong J, Quinn CM, Brown AJ (2006) SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem J 400: 485-491. (Pubitemid 44974460)
47. Ross SE, Erickson RL, Gerin I, DeRose PM, Bajnok L, et al. (2002) Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol 22: 5989-5999. (Pubitemid 34815845)
48. Tan SX, Ng Y, Meoli CC, Kumar A, Khoo PS, et al. (2012) Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J Biol Chem 287: 6128-6138.
49. Stephens JM, Pekala PH (1991) Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 266: 21839-21845. (Pubitemid 121000258)
50. Kozka IJ, Clark AE, Holman GD (1991) Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes. J Biol Chem 266: 11726-11731. (Pubitemid 21907009)
51. Flores-Riveros JR, McLenithan JC, Ezaki O, Lane MD (1993) Insulin downregulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci U S A 90: 512-516. (Pubitemid 23028893)
52. Rossetti L, Stenbit AE, Chen W, Hu M, Barzilai N, et al. (1997) Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest 100: 1831-1839. (Pubitemid 27431342)
53. Pedersen O, Kahn CR, Flier JS, Kahn BB (1991) High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats. Endocrinology 129: 771-777.
54. Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, et al. (1991) Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest 87: 1072-1081.